OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Insulin-like growth factor II prevents oxidative and neuronal damage in cellular and mice models of Parkinson's disease
Elisa Martín‐Montañez, Nadia Valverde, David Ladrón de Guevara‐Miranda, et al.
Redox Biology (2021) Vol. 46, pp. 102095-102095
Open Access | Times Cited: 27
Elisa Martín‐Montañez, Nadia Valverde, David Ladrón de Guevara‐Miranda, et al.
Redox Biology (2021) Vol. 46, pp. 102095-102095
Open Access | Times Cited: 27
Showing 1-25 of 27 citing articles:
IGF2 in memory, neurodevelopmental disorders, and neurodegenerative diseases
Cristina M. Alberini
Trends in Neurosciences (2023) Vol. 46, Iss. 6, pp. 488-502
Closed Access | Times Cited: 30
Cristina M. Alberini
Trends in Neurosciences (2023) Vol. 46, Iss. 6, pp. 488-502
Closed Access | Times Cited: 30
Insulin-like growth factor 2 and autophagy gene expression alteration arise as potential biomarkers in Parkinson’s disease
Denisse Sepúlveda, Felipe Grünenwald, A. Vidal, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 24
Denisse Sepúlveda, Felipe Grünenwald, A. Vidal, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 24
Causal relationships between type 1 diabetes mellitus and Alzheimer’s disease and Parkinson’s disease: a bidirectional two-sample Mendelian randomization study
Chaofan Geng, Ke Meng, Bo Zhao, et al.
European journal of medical research (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 5
Chaofan Geng, Ke Meng, Bo Zhao, et al.
European journal of medical research (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 5
Potential Protective Link Between Type I Diabetes and Parkinson's Disease Risk and Progression
Konstantin Senkevich, Paria Alipour, Ekaterina А. Chernyavskaya, et al.
Movement Disorders (2023) Vol. 38, Iss. 7, pp. 1350-1355
Open Access | Times Cited: 11
Konstantin Senkevich, Paria Alipour, Ekaterina А. Chernyavskaya, et al.
Movement Disorders (2023) Vol. 38, Iss. 7, pp. 1350-1355
Open Access | Times Cited: 11
Research progress of small-molecule natural medicines for the treatment of ischemic stroke
Kui Liu, Ling Wang, Tao Pang
Chinese Journal of Natural Medicines (2025) Vol. 23, Iss. 1, pp. 21-30
Closed Access
Kui Liu, Ling Wang, Tao Pang
Chinese Journal of Natural Medicines (2025) Vol. 23, Iss. 1, pp. 21-30
Closed Access
Molecular epidemiological study of exosomes circZNF609, circPUM1, IGF2 with ischemic stroke
Suhai Fei, Miao Xu, Zhihong Liu, et al.
BMC Cardiovascular Disorders (2025) Vol. 25, Iss. 1
Open Access
Suhai Fei, Miao Xu, Zhihong Liu, et al.
BMC Cardiovascular Disorders (2025) Vol. 25, Iss. 1
Open Access
Felipe Grünenwald, Tomas Javier Huerta, Denisse Sepúlveda, et al.
Aging Cell (2025)
Open Access
Microglia Sirt6 modulates the transcriptional activity of NRF2 to ameliorate high-fat diet-induced obesity
Xiaoxia Xiao, Huiling Hu, Yadi Zhong, et al.
Molecular Medicine (2023) Vol. 29, Iss. 1
Open Access | Times Cited: 9
Xiaoxia Xiao, Huiling Hu, Yadi Zhong, et al.
Molecular Medicine (2023) Vol. 29, Iss. 1
Open Access | Times Cited: 9
New molecular mechanisms to explain the neuroprotective effects of insulin-like growth factor II in a cellular model of Parkinson’s disease
Silvana Y. Romero‐Zerbo, Nadia Valverde, Silvia Claros, et al.
Journal of Advanced Research (2024)
Open Access | Times Cited: 3
Silvana Y. Romero‐Zerbo, Nadia Valverde, Silvia Claros, et al.
Journal of Advanced Research (2024)
Open Access | Times Cited: 3
Effect of Different MPTP Administration Intervals on Mouse Models of Parkinson’s Disease
Yuanyuan Ma, Qiongwen Rong
Contrast Media & Molecular Imaging (2022) Vol. 2022, Iss. 1
Open Access | Times Cited: 15
Yuanyuan Ma, Qiongwen Rong
Contrast Media & Molecular Imaging (2022) Vol. 2022, Iss. 1
Open Access | Times Cited: 15
Αnti-prion effects of anthocyanins
Nikoletta Christoudia, Nikolaos Bekas, Ειrini Kanata, et al.
Redox Biology (2024) Vol. 72, pp. 103133-103133
Open Access | Times Cited: 2
Nikoletta Christoudia, Nikolaos Bekas, Ειrini Kanata, et al.
Redox Biology (2024) Vol. 72, pp. 103133-103133
Open Access | Times Cited: 2
Neuroprotective effects of insulin-like growth factor-2 in 6-hydroxydopamine-induced cellular and mouse models of Parkinson’s disease
Kaifu Ke, Xiao-Su Gu, Hai‐Ying Zhang, et al.
Neural Regeneration Research (2022) Vol. 18, Iss. 5, pp. 1099-1099
Open Access | Times Cited: 11
Kaifu Ke, Xiao-Su Gu, Hai‐Ying Zhang, et al.
Neural Regeneration Research (2022) Vol. 18, Iss. 5, pp. 1099-1099
Open Access | Times Cited: 11
IGF2 deficiency promotes liver aging through mitochondrial dysfunction and upregulated CEBPB signaling in d-galactose-induced aging mice
Xiaohai Zhou, Bowen Tan, Weiwei Gui, et al.
Molecular Medicine (2023) Vol. 29, Iss. 1
Open Access | Times Cited: 6
Xiaohai Zhou, Bowen Tan, Weiwei Gui, et al.
Molecular Medicine (2023) Vol. 29, Iss. 1
Open Access | Times Cited: 6
IGF2 prevents dopaminergic neuronal loss and decreases intracellular alpha-synuclein accumulation in Parkinson’s disease models
Javiera Arcos, Felipe Grünenwald, Denisse Sepúlveda, et al.
Cell Death Discovery (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 5
Javiera Arcos, Felipe Grünenwald, Denisse Sepúlveda, et al.
Cell Death Discovery (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 5
Reduced Hippocampal and Anterior Cingulate Expression of Antioxidant Enzymes and Membrane Progesterone Receptors in Alzheimer’s Disease with Depression
Wendy Luo, Katherine J. Pryzbyl, Eileen H. Bigio, et al.
Journal of Alzheimer s Disease (2022) Vol. 89, Iss. 1, pp. 309-321
Open Access | Times Cited: 8
Wendy Luo, Katherine J. Pryzbyl, Eileen H. Bigio, et al.
Journal of Alzheimer s Disease (2022) Vol. 89, Iss. 1, pp. 309-321
Open Access | Times Cited: 8
The critical roles of IGFs in immune modulation and inflammation
Xin Wang, Lijuan Cao, Shisong Liu, et al.
Cytokine (2024) Vol. 183, pp. 156750-156750
Closed Access | Times Cited: 1
Xin Wang, Lijuan Cao, Shisong Liu, et al.
Cytokine (2024) Vol. 183, pp. 156750-156750
Closed Access | Times Cited: 1
Therapeutic benefits of factors derived from stem cells from human exfoliated deciduous teeth for radiation-induced mouse xerostomia
Fumiya Kano, Noboru Hashimoto, Yao Liu, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 3
Fumiya Kano, Noboru Hashimoto, Yao Liu, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 3
Insulin-like Growth Factor II Prevents MPP+ and Glucocorticoid Mitochondrial-Oxidative and Neuronal Damage in Dopaminergic Neurons
Silvia Claros, P. CABRERA, Nadia Valverde, et al.
Antioxidants (2021) Vol. 11, Iss. 1, pp. 41-41
Open Access | Times Cited: 7
Silvia Claros, P. CABRERA, Nadia Valverde, et al.
Antioxidants (2021) Vol. 11, Iss. 1, pp. 41-41
Open Access | Times Cited: 7
Iron‐inhibited autophagy via transcription factor ZFP27 in Parkinson's disease
Yinying Wang, Qian Wen, Rongsha Chen, et al.
Journal of Cellular and Molecular Medicine (2023) Vol. 27, Iss. 22, pp. 3614-3627
Open Access | Times Cited: 2
Yinying Wang, Qian Wen, Rongsha Chen, et al.
Journal of Cellular and Molecular Medicine (2023) Vol. 27, Iss. 22, pp. 3614-3627
Open Access | Times Cited: 2
IGF2-reprogrammed macrophages ameliorate the inflammatory response and protects against the neurodegenerative and neuroinflammatory process in Parkinson`s disease models.
Felipe Grünenwald, Tomas Javier Huerta, Denisse Sepúlveda, et al.
Research Square (Research Square) (2024)
Open Access
Felipe Grünenwald, Tomas Javier Huerta, Denisse Sepúlveda, et al.
Research Square (Research Square) (2024)
Open Access
Association between serum insulin-like growth factor 1 and osteoporosis risk in Parkinson's disease: a cross-sectional study
Chaofan Geng, Chen Chen
Neurological Sciences (2024) Vol. 45, Iss. 11, pp. 5291-5296
Closed Access
Chaofan Geng, Chen Chen
Neurological Sciences (2024) Vol. 45, Iss. 11, pp. 5291-5296
Closed Access
IGF-II conjugated nanocarrier for brain targeting
Likhit Akotkar, Urmila Aswar, S. Deshmukh Shruti, et al.
Elsevier eBooks (2024), pp. 61-77
Closed Access
Likhit Akotkar, Urmila Aswar, S. Deshmukh Shruti, et al.
Elsevier eBooks (2024), pp. 61-77
Closed Access
IGF2 confers genetic susceptibility to the risk of ischemic stroke with differential mRNA expression in leukocytes
Xie Hai-ning, Changying Chen, Xu Han, et al.
Research Square (Research Square) (2024)
Open Access
Xie Hai-ning, Changying Chen, Xu Han, et al.
Research Square (Research Square) (2024)
Open Access
Potential protective link between type I diabetes and Parkinson’s disease risk and progression
Konstantin Senkevich, Paria Alipour, Ekaterina А. Chernyavskaya, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 1
Konstantin Senkevich, Paria Alipour, Ekaterina А. Chernyavskaya, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 1
The Neuroprotective Mechanism of IGF-2 in Neuromyelitis optica spectrum disorder
Yingyu Zhang, Na Xu, Kaikai Yu, et al.
Research Square (Research Square) (2023)
Open Access
Yingyu Zhang, Na Xu, Kaikai Yu, et al.
Research Square (Research Square) (2023)
Open Access
